Delivery Order SPE2DB22D1106-SPE2DB25FFAZ0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of VIMPAT 200 MG tablets in a quantity of 60 units, with a contract ceiling value of $1,089.82. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract has an ultimate completion date of July 28, 2025, and AmerisourceBergen will perform this work from its corporate office location in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,438.46 firm fixed-price delivery order is for the supply of VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,006.22 delivery order contract is for the supply of VIMPAT 100 MG Tablets, a medication used to treat epilepsy. The contract is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. It is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,682.43, is for the supply of VIMPAT 100 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of February 20, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award, valued at $1,678.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of May 16, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
- The federal contract award is for the delivery of VIMPAT 100 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $5,208.71 firm-fixed price delivery order was awarded on May 22, 2025, with a completion date of May 23, 2025. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 200 MG TABLET 60S, a prescription medication, with a ceiling value of $3,318.54 and a completion date of August 8, 2022. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating it was awarded...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VIMPAT 200 MG TABLET 60S, a pharmaceutical product. The $2,501.60 firm-fixed-price contract has a completion date of September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medication tablets under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565165565 VIMPAT 100 MG TABLET 60S. The contract has a ceiling value of $1,415.46 and a completion date of July 17, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen is the prime contractor, and the contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $2,075.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562031754 VIMPAT 100 MG TABLET 60S. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DOD and other federal customers. Amerisourcebergen will deliver the VIMPAT tablets to a customer located in Conshohocken, Pennsylvania, completing performance by September 5, 2023. The funding agency, DLA, manages...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAZ0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of VIMPAT 100 mg at a ceiling value of $1,089.84 under a firm fixed price contract type. This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables global pharmaceutical supply to military healthcare programs. VIMPAT (lacosamide) is a prescription medication used for seizure management and neuropathic pain conditions, making this order consistent with AmerisourceBergen's extensive portfolio of neurological and specialty medications supplied to federal healthcare systems. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare procurement, AmerisourceBergen regularly fulfills federal medical supply needs through the DLA's Medical Supply Chain, serving organizations including the Defense Health Agency and U.S. Coast Guard. The firm fixed pricing structure and non-set-aside competitive award designation reflect the company's demonstrated capability to meet federal procurement requirements through open competition in the pharmaceutical distribution sector.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/31/25 |